Di Francesco Alexander, Flamini Stefano, Zugaro Luigi, Zoccali Carmine
Department of Orthopaedic Surgery, San Salvatore Hospital, via Vetoio, No 1, 67100 L'Aquila, Italy.
Acta Orthop Belg. 2012 Aug;78(4):523-30.
This study aimed to determine whether Radiofrequency Ablation (RFA) followed by prophylactic internal fixation produces better palliation in terms of pain and reduces the need for blood transfusion more than radiotherapy and surgical stabilization (RT-SS). Patients with solitary long bone metastases and a pain score of 5 or more on the VAS scale were selected. Fifteen patients were treated with RFA and surgical stabilization (RFA-SS) and were compared with a matched group (15 subjects) treated by radiotherapy and surgical stabilization (RT-SS). A complete response in terms of pain relief at 12 weeks was documented in 20% (3/15) and 533% (8/15) of the subjects treated by RT-SS or RFA-SS, respectively (p = 0.027). The overall response rate at 12 weeks was 93.3% (14 patients) in the group treated by RFA-SS and 59.9% (9 patients) in the group treated by RT-SS (p = 0.048). Although recurrent pain was documented more frequently after RT-SS (26.6%) than after RFA-SS (6.7%) the difference did not reach statistical significance. The morbidity related to RT-SS did not significantly differ when the treatment was associated with RFA. We observed a reduction in blood transfusion, as 3 patients in the RT-SS group required a blood transfusion, versus none in the RFA-SS group. Our results suggest that RFA-SS is safe and is more effective than RT-SS; furthermore, RFA may become an option for patients with metastases of the long bones to prevent tumour dissemination and reduce intraoperative blood loss. The findings described here should serve as a framework around which to design future clinical trials.
本研究旨在确定射频消融(RFA)联合预防性内固定在缓解疼痛方面是否比放射治疗和手术稳定(RT-SS)产生更好的姑息效果,以及是否能更多地减少输血需求。选择了孤立性长骨转移且视觉模拟评分(VAS)为5分或更高的患者。15例患者接受了RFA和手术稳定(RFA-SS)治疗,并与接受放射治疗和手术稳定(RT-SS)的匹配组(15名受试者)进行比较。RT-SS或RFA-SS治疗的受试者中,分别有20%(3/15)和53.3%(8/15)在12周时记录到疼痛缓解的完全缓解(p = 0.027)。RFA-SS治疗组在12周时的总体缓解率为93.3%(14例患者),RT-SS治疗组为59.9%(9例患者)(p = 0.048)。虽然RT-SS后复发性疼痛的记录频率(26.6%)高于RFA-SS后(6.7%),但差异未达到统计学意义。当治疗与RFA联合时,与RT-SS相关的发病率没有显著差异。我们观察到输血减少,RT-SS组有3例患者需要输血,而RFA-SS组无患者需要输血。我们的结果表明,RFA-SS是安全的,并且比RT-SS更有效;此外,RFA可能成为长骨转移患者预防肿瘤播散和减少术中失血的一种选择。此处描述的研究结果应作为设计未来临床试验的框架。